Second edition of MENA Microbiome 2026 opens
<p>Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, yesterday opened the second edition of the MENA Microbiome Conference 2026 in Doha, bringing together leading researchers, physicians, scientists, industry experts, partners, and sponsors to explore the latest advances in microbiome science and their potential applications in healthcare.</p> <p>Held under the theme ‘From Biomarkers…
Doha, Qatar - The Sidra Medicine, a part of Qatar Foundation, inaugurated the second annual MENA Microbiome Conference 2026 yesterday, convening eminent researchers, physicians, scientists, industry specialists, partners, and sponsors. The event focused on unveiling recent breakthroughs in microbiome research and their prospective applications in healthcare.
The opening day's discussions centered on the microbiome's role in women's and children's health, precision nutrition, and innovative therapeutic approaches. Co-Chairs Dr. Souhaila Al Khodor and Dr. Annalisa Terranega unveiled research on the impact of the maternal microbiome on an infant's microbial development during the crucial first 1,000 days of life. They also explored the significance of the breast milk microbiome in infant health and the effect of pregnancy complications on early immune-microbiome interactions.
Other sessions delved into the latest developments in pediatric microbiome research. Dr. Nikhil Pai discussed the clinical applications, safety considerations, and infrastructure requirements for pediatric donor stool banks. Prof. Mamoun Elawad from Sidra Medicine examined the gut microbiome's role in pediatric organ transplantation and its potential implications for patient outcomes.
Dr. Souhaila Al Khodor, Director of the Reproductive and Perinatal Health Translational Research Programme and Principal Investigator at Sidra Medicine, announced the establishment of QMicrobe. This initiative, in collaboration with Dr. Majdi Osman from Cambridge University, aims to gather samples from carefully screened healthy pediatric donors to investigate microorganisms and microbial functions that may have therapeutic potential.
Dr. Osman's presentation touched upon advances in fecal microbiota transplantation and emerging microbial therapies, discussing current clinical applications, ongoing research, and the opportunities and challenges in developing microbiome-based treatments.
Written by urgent.news from The Peninsula Qatar's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
